The effect of an oral anti-oxidant, N-Acetyl-cysteine, on inflammatory and oxidative markers in pulmonary sarcoidosis
- 1 March 2016
- journal article
- research article
- Published by Elsevier in Respiratory Medicine
- Vol. 112, 106-111
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Existing and potential therapeutic uses for N-acetylcysteine: The need for conversion to intracellular glutathione for antioxidant benefitsPharmacology & Therapeutics, 2014
- Systemic oxidative stress in patients with pulmonary sarcoidosisPulmonary Pharmacology & Therapeutics, 2009
- Antioxidant status associated with inflammation in sarcoidosis: A potential role for antioxidantsRespiratory Medicine, 2009
- Treatment of SarcoidosisClinics in Chest Medicine, 2008
- 8-Isoprostane, a Marker of Oxidative Stress, Is Increased in the Expired Breath Condensate of Patients With Pulmonary SarcoidosisChest, 2004
- The effect of N-acetylcysteine on nuclear factor-κB activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis*Critical Care Medicine, 2003
- Statement on SarcoidosisAmerican Journal of Respiratory and Critical Care Medicine, 1999
- 8-Isoprostane as a Biomarker of Oxidative Stress in Interstitial Lung DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 1998
- N-ACETYL CYSTEINE ATTENUATES ACUTE LUNG INJURY IN THE RATShock, 1997
- Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?The Lancet, 1994